Vitamins on Semaglutide: Biomarker-Guided Supplementation

Last reviewed: May 26, 2026

Last updated: May 26, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Semaglutide significantly reduces appetite and slows gastric emptying, both of which can impair nutrient absorption and increase micronutrient deficiency risk. Research shows GLP-1 agonists may lower B12, folate, and iron status over time, making strategic supplementation essential for long-term health and metabolic outcomes.

Standard vitamin recommendations often miss the mark because they ignore individual variation in nutrient metabolism and absorption capacity. PlexusDx precision-wellness approach helps you understand your unique nutritional needs based on baseline biomarkers and genetic predispositions in nutrient-transport pathways—enabling you to work with your provider on truly personalized supplementation.

How Semaglutide Affects Micronutrient Status

Semaglutide delays gastric emptying and reduces overall food intake, both mechanisms that can lower nutrient bioavailability. Diminished stomach acid production and reduced food volume mean fewer nutrients reach your intestinal absorption sites, compounding deficiency risk over months of treatment.

Clinical literature documents semaglutide-associated declines in B12, folate, iron, and calcium in longitudinal cohorts. These aren't rare side effects; they reflect the drug's mechanism. Baseline nutritional status and individual absorption capacity predict which users face highest deficiency risk, making pre-treatment assessment valuable.

Essential Vitamins and Biomarker Targets for Semaglutide Users

Not all vitamins require supplementation equally. Your baseline biomarkers and genetic predispositions determine which micronutrients warrant active monitoring and supplementation. Below is a framework for evaluating micronutrient priorities based on semaglutide's mechanism and evidence.

Micronutrient	Semaglutide Risk Factor	Key Biomarker	Typical Dose Range
Vitamin B12	Reduced intrinsic factor; lower stomach acid	Serum B12 <400 pg/mL or elevated methylmalonic acid	1000–2000 mcg weekly IM or 1000–2000 mcg daily oral
Folate	Reduced food intake and absorption	RBC folate <280 ng/mL; elevated homocysteine	400–1000 mcg daily (methylfolate preferred)
Iron	Lower stomach acid reduces ferrous absorption	Ferritin <30 ng/mL; low hemoglobin or MCHC	18–27 mg elemental iron daily (separate from other supplements)
Calcium	Reduced intake + impaired vitamin D–mediated absorption	Serum calcium, 25-OH vitamin D <30 ng/mL	500–1000 mg daily with vitamin D3 (2000–4000 IU)

Genetic Predispositions in Nutrient Metabolism Pathways

Individual variation in genes encoding nutrient transporters and metabolic enzymes means some users absorb or utilize micronutrients less efficiently. Variants in genes like MTHFR, MTR, and iron-metabolism pathways can predict who requires higher supplemental doses or more frequent biomarker monitoring.

PlexusDx Precision Peptide Genetic Test includes assessment of predispositions in nutrient-metabolism pathways that interact with GLP-1 physiology. This information may help provide context for your provider's supplementation strategy, allowing more targeted and evidence-based dose selection rather than generic recommendations.

When and How to Test: A Provider-Guided Framework

Baseline micronutrient testing before starting semaglutide and repeat testing at 3, 6, and 12 months gives you objective data to guide supplementation adjustments. Standard panels include serum B12, folate, iron studies, and vitamin D; more advanced testing may assess methylmalonic acid or homocysteine if deficiency is suspected.

Work with your provider to establish a monitoring schedule and adjust supplementation based on trends rather than symptoms alone. Early detection of declining biomarkers allows intervention before deficiency-related fatigue, neuropathy, or bone loss occurs. Never supplement aggressively without biomarker guidance; excess B6, folate, or iron can cause harm.

Safety Considerations and When to Seek Provider Guidance

Certain supplements interact with semaglutide or worsen its side effects. High-dose calcium or iron taken with semaglutide may delay absorption of both; separating doses by 2+ hours reduces risk. Herbal supplements claiming appetite suppression or metabolism boost are not evidence-based and may conflict with your treatment goals.

If you have a history of anemia, vitamin B12 deficiency, celiac disease, inflammatory bowel disease, or kidney disease, you are at heightened risk for micronutrient complications on semaglutide. Discuss supplementation needs with your healthcare provider before starting treatment. Genetic testing may reveal additional risk factors in nutrient-metabolism pathways that warrant earlier or more aggressive monitoring.

How PlexusDx Supports a More Personalized Approach

PlexusDx Precision Peptide Genetic Test assesses predispositions in nutrient-metabolism pathways—including iron transport, folate utilization, and vitamin B12 absorption—that interact with semaglutide's mechanism. This genetic context may help provide evidence for personalized supplementation strategies when interpreted alongside your baseline biomarker profile and clinical history.

The test reveals variants in genes such as MTHFR, SLC23A1 (vitamin C transport), and hepcidin-related iron regulation that predict individual nutrient-absorption and metabolism capacity. These predispositions do not guarantee exact supplementation needs but can support a more informed conversation with your provider about which micronutrients warrant earlier monitoring or higher baseline doses.

Combining genetic insights with objective biomarker data and your unique semaglutide response allows your provider to move beyond generic vitamin protocols toward precision supplementation—reducing deficiency risk while avoiding unnecessary supplemental burden and drug–nutrient interactions.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral starts at $229-$509/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.